M Abu-Khalaf - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

M Abu-Khalaf

Showing results (41-50 of 46) with videos related to

Pageof 5

Sort By:

You have reached the last page of results.This site can display upto 46 results.

Cancer|March 13, 2016

Patient preferences regarding incidental genomic findings discovered during tumor profilingMelinda L Yushak, Gang Han, Sara Bouberhan, et al.

British Journal of Cancer|November 19, 2009

In vitro activity of pertuzumab in combination with trastuzumab in uterine serous papillary adenocarcinomaK El-Sahwi, S Bellone, E Cocco, et al.

NPJ Precision Oncology|February 16, 2023

AKT/mTOR signaling modulates resistance to endocrine therapy and CDK4/6 inhibition in metastatic breast cancersMaysa M Abu-Khalaf, K Alex Hodge, Christos Hatzis, et al.

Cancer|February 5, 2015

Phase 1b study of the mammalian target of rapamycin inhibitor sirolimus in combination with nanoparticle albumin-bound paclitaxel in patients with advanced solid tumorsMaysa M Abu-Khalaf, Megan A Baumgart, Scott N Gettinger, et al.

Breast Cancer Research and Treatment|May 6, 2020

Prognostic value of HER2 status on circulating tumor cells in advanced-stage breast cancer patients with HER2-negative tumorsChun Wang, Zhaomei Mu, Zhong Ye, et al.

European Journal of Cancer (Oxford, England : 1990)|December 12, 2018

Association of clinical outcomes in metastatic breast cancer patients with circulating tumour cell and circulating cell-free DNAZhong Ye, Chun Wang, Shaogui Wan, et al.

Pageof 5

Search research articles

Showing results (41-50 of 46) with videos related to

Sort By:

Pageof 5

You have reached the last page of results.This site can display upto 46 results.

Cancer|March 13, 2016

Patient preferences regarding incidental genomic findings discovered during tumor profilingMelinda L Yushak, Gang Han, Sara Bouberhan, et al.

British Journal of Cancer|November 19, 2009

In vitro activity of pertuzumab in combination with trastuzumab in uterine serous papillary adenocarcinomaK El-Sahwi, S Bellone, E Cocco, et al.

NPJ Precision Oncology|February 16, 2023

AKT/mTOR signaling modulates resistance to endocrine therapy and CDK4/6 inhibition in metastatic breast cancersMaysa M Abu-Khalaf, K Alex Hodge, Christos Hatzis, et al.

Cancer|February 5, 2015

Breast Cancer Research and Treatment|May 6, 2020

Prognostic value of HER2 status on circulating tumor cells in advanced-stage breast cancer patients with HER2-negative tumorsChun Wang, Zhaomei Mu, Zhong Ye, et al.

European Journal of Cancer (Oxford, England : 1990)|December 12, 2018

Association of clinical outcomes in metastatic breast cancer patients with circulating tumour cell and circulating cell-free DNAZhong Ye, Chun Wang, Shaogui Wan, et al.

Pageof 5